Preclinical Development of Cell-Based Products: A European Regulatory Science Perspective

Pharmaceutical Research - United States
doi 10.1007/s11095-018-2437-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Embedding Science in Society: A European Perspective

Journal of Science Communication
Communication
2009English

Characterization of Nanomedicine in Terms of Regulatory Science Perspective

Drug Delivery System
Pharmaceutical Science
2019English

Preclinical Development of an Automated Injection Device for Intradermal Delivery of a Cell-Based Therapy

Drug Delivery and Translational Research
Pharmaceutical Science
2017English

ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Regulatory Consequences of “Brexit” for the Development of Medicinal Products

Clinical Pharmacology and Therapeutics
Pharmacology
2017English

Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development

PLoS ONE
Multidisciplinary
2015English

Equal Opportunities via Community Development: European Perspective

Socialinė teorija, empirija, politika ir praktika
2007English

Regulatory Science

2020English

Athlete Development, Athlete Rights and Athlete Welfare: A European Union Perspective

International Journal of the History of Sport
Sports ScienceSocial SciencesHistory
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy